Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      US court rules against Ranbaxy, supports Pfizer patent


      NEW YORK, November 24 ( "The court of appeals for the federal circuit in Washington on Wednesday upheld a preliminary injunction granted by the US district court of New Jersey, barring Ranbaxy Pharmaceuticals Inc from marketing a generic version of Pfizer's (PFE.NYS) Quinapril HCI tablets.

      The US Court of Appeals for the Federal Circuit Wednesday affirmed Judge Dickinson R Debevoise's earlier order to stop selling a generic version of Pfizer's Accupril drug by Gurgaon, India-based Ranbaxy Pharmaceuticals, a subsidiary of Ranbaxy Laboratories (RLYG). Pfizer said that it would seek damages from Ranbaxy and co-promoter Teva Pharmaceutical Industries (TEVA) for lost revenues from Quinapril. Ranbaxy's share price fell Rs.8.1 or 2.2% to Rs.368.8 on the Mumbai stock exchange on Thursday.

      November 24, 2005


      Share this Article!

    Back to top^